Schöni M - Search Results

1

Clinical presentation of celiac disease and the diagnostic accuracy of serologic markers in children.

Lurz E, Scheidegger U, Spalinger J, Schöni M, Schibli S. Lurz E, et al. Among authors: schoni m. Eur J Pediatr. 2009 Jul;168(7):839-45. doi: 10.1007/s00431-008-0845-4. Epub 2008 Oct 16. Eur J Pediatr. 2009. PMID: 18923841 Free article.

2

One-year evaluation of a neonatal screening program for cystic fibrosis in Switzerland.

Rueegg CS, Kuehni CE, Gallati S, Baumgartner M, Torresani T, Barben J; Swiss CF Screening Task Force. Rueegg CS, et al. Dtsch Arztebl Int. 2013 May;110(20):356-63. doi: 10.3238/arztebl.2013.0356. Epub 2013 May 17. Dtsch Arztebl Int. 2013. PMID: 23825488 Free PMC article.

3

Staphylococcus aureus septicaemia in a patient with cystic fibrosis.

Aebischer CC, Aebi C, Schöni MH. Aebischer CC, et al. Among authors: schoni mh. Eur J Pediatr. 2000 Sep;159(9):689-91. doi: 10.1007/pl00008408. Eur J Pediatr. 2000. PMID: 11014470

4

A new baby-spacer device for aerosolized bronchodilator administration in infants with bronchopulmonary disease.

Kraemer R, Birrer P, Modelska K, Aebischer CC, Schöni MH. Kraemer R, et al. Among authors: schoni mh. Eur J Pediatr. 1992 Jan;151(1):57-60. doi: 10.1007/BF02073894. Eur J Pediatr. 1992. PMID: 1728549

5

Compliance with therapy in children with respiratory diseases.

Schöni MH, Horak E, Nikolaizik WH. Schöni MH, et al. Eur J Pediatr. 1995;154(9 Suppl 4):S77-81. doi: 10.1007/BF02191512. Eur J Pediatr. 1995. PMID: 8529717 Clinical Trial.

6

Bronchial constriction after nebulized tobramycin preparations and saline in patients with cystic fibrosis.

Nikolaizik WH, Jenni-Galović V, Schöni MH. Nikolaizik WH, et al. Among authors: schoni mh. Eur J Pediatr. 1996 Jul;155(7):608-11. doi: 10.1007/BF01957914. Eur J Pediatr. 1996. PMID: 8831087

7

Pilot study to assess the effect of inhaled corticosteroids on lung function in patients with cystic fibrosis.

Nikolaizik WH, Schöni MH. Nikolaizik WH, et al. Among authors: schoni mh. J Pediatr. 1996 Feb;128(2):271-4. doi: 10.1016/s0022-3476(96)70407-9. J Pediatr. 1996. PMID: 8636828 Clinical Trial.

8

Growth in prepubertal children with cystic fibrosis, homozygous for the Delta F508 mutation.

Keller BM, Aebischer CC, Kraemer R, Schöni MH. Keller BM, et al. Among authors: schoni mh. J Cyst Fibros. 2003 Jun;2(2):76-83. doi: 10.1016/S1569-1993(03)00023-7. J Cyst Fibros. 2003. PMID: 15463854 Free article.

9

Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection.

Lang AB, Rüdeberg A, Schöni MH, Que JU, Fürer E, Schaad UB. Lang AB, et al. Pediatr Infect Dis J. 2004 Jun;23(6):504-10. doi: 10.1097/01.inf.0000129688.50588.ac. Pediatr Infect Dis J. 2004. PMID: 15194830

10

High morbidity and mortality in cystic fibrosis patients compound heterozygous for 3905insT and deltaF508.

Schibler A, Bolt I, Gallati S, Schöni MH, Kraemer R. Schibler A, et al. Among authors: schoni mh. Eur Respir J. 2001 Jun;17(6):1181-6. doi: 10.1183/09031936.01.00034601. Eur Respir J. 2001. PMID: 11491162 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters